The ethical assignment of authorship in scientific publications: Issues and guidelines

Academic Emergency Medicine

Volumn 15, Issue 10, 2008, Pages 963-969

  Feeser, V Ramana ^a   Simon, Jeremy R ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Authorship; Ethics; Research

Indexed keywords

CONFERENCE PAPER; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; WRITING;

AUTHORSHIP; BIOMEDICAL RESEARCH; ETHICS, RESEARCH; HUMANS; ORGANIZATIONAL POLICY; PUBLISHING;

EID: 56849108799     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2008.00239.x     Document Type: Conference Paper

References (37)

1. Adams J, Schmidt T, Sanders A, Larkin GL, Knopp R. Professionalism in emergency medicine. SAEM Ethics Committee. Society for Academic Emergency Medicine. Acad Emerg Med. 1998; 5:1193-9.
2. Frazzetto G. Who did what? Uneasiness with the current authorship is prompting the scientific community to seek alternatives. EMBO Rep. 2004; 5:446-8.
3. Powers RD, Calkins KK. Multiple authorship revisited: how much is enough? Am J Emerg Med. 1998; 7:708-9.
4. Papatheodorou SI, Trikalinos TA, Ioannidis JP. Inflated numbers of authors over time have not been just due to increasing research complexity. J Clin Epidemiol. 2008; 61:546-51.
5. Angell M. Publish or perish: a proposal. Ann Intern Med. 1986; 104:261-2.
6. Wilson R. A higher bar for earning tenure. Chron Higher Educ. 2001; 47:A12-4.
7. Rennie D, Yank V, Emanuel L. When authorship fails: a proposal to make contributors accountable. JAMA. 1997; 278:579-85.
8. Flanagin A, Carey LA, Fontanarosa PB, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998; 280:222-4.
9. Wilcox L. Authorship: the coin of the realm, the source of complaints. JAMA. 1998; 280:216-7.
10. Shahan JB, Kelen GD. Research ethics. Emerg Med Clin North Am. 2006; 2:657-69.
11. Bennett D, Taylor D. Unethical practices in authorship of scientific papers. Emerg Med. 2003; 15:263-70.
12. Mowatt G, Shirran L, Grimshaw JM, et al. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA. 2002; 287:2769-71.
13. Claxton LD. Scientific authorship: part 2. history, recurring issues, practices, and guidelines. Mutat Res. 2005; 589:31-45.
14. The World Association of Medical Editors. Ghost writing initiated by commercial companies. J Gen Intern Med. 2005; 20:549.
15. Gøtzche PC, Hróbjartsson A, Johansen HK, et al. Ghost authorship in industry-initiated randomized trials. PLoS Med. 2007; 4:e19.
16. Gaeta TJ. Authorship: "law" and order. Acad Emerg Med. 1999; 6:297-301.
17. Marco CA, Schmidt TA. Who wrote this paper? Basics of authorship and ethical issues. Acad Emerg Med. 2004; 11:76-7.
18. Shapiro DW, Wenger NS, Shapiro MF. The contributions of authors to multiauthored biomedical research papers. JAMA. 1994; 271:438-42.
19. Unsigned. Honorary authorship. Nature. 1995; 375:522.
20. Smith R. Research misconduct: the poisoning of the well. J R Soc Med. 2006; 99:232-7.
21. Fugh-Berman A. The corporate coauthor. J Gen Intern Med. 2005; 20:546-8.
22. Tierney WM, Gerrity MS. Scientific discourse, corporate ghostwriting, journal policy and public trust. J Gen Intern Med. 2005; 20:550-1.
23. DeAngelis CD, Fontanarosa PB. Impugning the integrity of medical science: the adverse effects of industry influence. JAMA. 2008; 299:1833-5.
24. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA. 2008; 299:1800-12.
25. Lisse JR, Perlman M, Johansson G, et al. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Ann Intern Med. 2003; 139:539-46.
26. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000; 343:1520-8.
27. Berenson A. Evidence in Vioxx suit shows intervention by Merck officials. New York Times. April 24, 2005:A1.
28. Curfman GD, Morrissey S, Drazen JM. Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000; 343:1520-8 [letter]. N Engl J Med. 2005; 353:2813-4.
29. Smith R. Authorship: time for a paradigm shift? Br Med J. 1997; 314:992.
30. Hoey J. Who wrote this paper anyway? CMAJ. 2000; 163:716-7.
31. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. Available at: http://www.icmje.org. Accessed Jan 12, 2008.
32. Callaham ML, Waeckerle JF. Deciphering the authorship code. Ann Emerg Med. 2001; 37:386-8.
33. Bhopal R, Rankin J, McColl E, Thomas L, Kaner E, Stacy R. The vexed question of authorship: views of researchers in a British medical faculty. Br Med J. 1997; 314:1009-12.
34. Bates T, Anić A, Marusić M, Marusić A. Authorship criteria and disclosure of contributions: comparison of 3 general medical journals with different author contribution forms. JAMA. 2004; 292:86-8.
35. Rennie D, Flanagin A, Yank V. The contributions of authors. JAMA. 2000; 284:89-91.
36. Ahmed SM, Maurana CA, Engle JA, Uddin DE, Glaus KD. A method for assigning authorship in multiauthored publications. Fam Med. 1997; 29:42-4.
37. Verhagen JV, Wallace KJ, Collins SC, Scott TR. QUAD system offers fair shares to all authors [letter]. Nature. 2003; 426:602.